Gerresheimer (GXI) Given a €64.00 Price Target by Deutsche Bank Analysts
Gerresheimer (ETR:GXI) has been given a €64.00 ($76.19) target price by investment analysts at Deutsche Bank in a note issued to investors on Friday. The firm presently has a “neutral” rating on the stock. Deutsche Bank’s price objective indicates a potential downside of 3.80% from the company’s previous close.
Other research analysts have also recently issued research reports about the company. Independent Research set a €68.00 ($80.95) price target on Gerresheimer and gave the stock a “neutral” rating in a research note on Tuesday, September 5th. Goldman Sachs Group set a €69.50 ($82.74) price target on Gerresheimer and gave the stock a “neutral” rating in a research note on Wednesday, October 4th. J P Morgan Chase & Co set a €99.40 ($118.33) price target on Gerresheimer and gave the stock a “buy” rating in a research note on Wednesday, October 11th. set a €65.00 ($77.38) price objective on Gerresheimer and gave the company a “neutral” rating in a report on Tuesday, October 17th. Finally, Berenberg Bank set a €75.00 ($89.29) price objective on Gerresheimer and gave the company a “buy” rating in a report on Wednesday, October 11th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of €72.64 ($86.48).
Gerresheimer (GXI) opened at €66.53 ($79.20) on Friday. Gerresheimer has a one year low of €59.97 ($71.39) and a one year high of €78.25 ($93.15).
ILLEGAL ACTIVITY WARNING: “Gerresheimer (GXI) Given a €64.00 Price Target by Deutsche Bank Analysts” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this article on another site, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/12/01/gerresheimer-gxi-given-a-64-00-price-target-by-deutsche-bank-analysts.html.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.